Health

AstraZeneca said on Tuesday that its infant immunisation against respiratory syncytial virus, developed with the help of Sanofi, has received approval in China. The drugmakers

Moderna shares rose nearly 14% on Tuesday as brokerage Oppenheimer upgraded the stock to “outperform” and the vaccine maker’s CEO reiterated the company’s goal of

AstraZeneca said Tuesday that its infant immunisation against respiratory syncytial virus, developed with the help of Sanofi, has won approval in China. The drugmakers have

Voyager Therapeutics said Novartis would pay $100 million upfront as part of a licensing agreement to develop gene therapy candidates. Voyager would provide Novartis with

34.6% of children between 12 and 13 years old admit having consumed alcohol, and 25% have smoked an electronic cigarette in Spain. This is the

Mead Johnson Nutrition, a Reckitt Benckiser Group company, is voluntarily recalling select lots of Nutramigen powder from the US market due to the possibility of

Drugmakers Pfizer, Sanofi and Takeda Pharmaceutical plan to raise the US prices of more than 500 drugs in early January, according to data analysed by

A US court upheld the Federal Trade Commission’s (FTC) order to block IQVIA’s acquisition of DeepIntent, a healthcare advertising company, on the grounds that it

Consulting firm McKinsey & Co has agreed to pay $78 million to settle claims by US health insurers and benefit plans that it contributed to

Swiss drugmaker Roche announced that it has agreed to buy LumiraDx’s Point of Care diagnostics platform for about $295m. LumiraDx shares rose 20% to 76